149 related articles for article (PubMed ID: 7188394)
1. Differences in immunogenicity between the local tumor 3LL and its metastasis-derived line as detected by sensitization with antigen-fed macrophages.
Brodt P; Segal S
Invasion Metastasis; 1982; 2(3):185-96. PubMed ID: 7188394
[TBL] [Abstract][Full Text] [Related]
2. An immune response against the alloantigens of the 3LL Lewis lung carcinoma prevents the growth of lung metastases, but not of local allografts.
Isakov N; Feldman M; Segal S
Invasion Metastasis; 1982; 2(1):12-32. PubMed ID: 6765248
[TBL] [Abstract][Full Text] [Related]
3. Induction of highly immunogenic variants of Lewis lung carcinoma tumor by ultraviolet irradiation.
Peppoloni S; Herberman RB; Gorelik E
Cancer Res; 1985 Jun; 45(6):2560-6. PubMed ID: 2580624
[TBL] [Abstract][Full Text] [Related]
4. Differences in resistance of metastatic tumor cells and cells from local tumor growth to cytotoxicity of natural killer cells.
Gorelik E; Fogel M; Feldman M; Segal S
J Natl Cancer Inst; 1979 Dec; 63(6):1397-404. PubMed ID: 292811
[TBL] [Abstract][Full Text] [Related]
5. Tumor-associated antigenic differences between the primary and the descendant metastatic tumor cell populations.
Gorelik E; Fogel M; Segal S; Feldman M
J Supramol Struct; 1979; 12(3):385-402. PubMed ID: 94933
[TBL] [Abstract][Full Text] [Related]
6. Macrophage involvement in the antitumoral effect of Nocardia-delipidated cell mitogen (NDCM).
Leibovici J; Hoenig S; Pinchassov A; Barot-Ciorbaru R
In Vivo; 1991; 5(4):365-74. PubMed ID: 1810422
[TBL] [Abstract][Full Text] [Related]
7. Influence of inoculation site on development of the Lewis lung carcinoma and suppressor cell activity in syngeneic mice.
Malavé I; Blanca I; Fuji H
J Natl Cancer Inst; 1979 Jan; 62(1):83-8. PubMed ID: 281579
[TBL] [Abstract][Full Text] [Related]
8. Control of lung metastasis progression in mice: role of growth kinetics of 3LL Lewis lung carcinoma and host immune reactivity.
Gorelik E; Segal S; Feldman M
J Natl Cancer Inst; 1980 Dec; 65(6):1257-64. PubMed ID: 6933271
[TBL] [Abstract][Full Text] [Related]
9. Selecting, accelerating and suppressing interactions between macrophages and tumor cells.
De Baetselier P; Kapon A; Katzav S; Tzehoval E; Dekegel D; Segal S; Feldman M
Invasion Metastasis; 1985; 5(2):106-24. PubMed ID: 3884534
[TBL] [Abstract][Full Text] [Related]
10. In vitro sensitization of human lymphocytes against allogeneic cells by antigen-fed macrophages.
Treves AJ; Heidelberger E; Feldman M; Kaplan HS
Isr J Med Sci; 1979 Jul; 15(7):564-9. PubMed ID: 478818
[TBL] [Abstract][Full Text] [Related]
11. [Role of the spleen in tumor immunity--with special reference to anti-tumor immunity induced by solubilized and purified tumor-associated antigen].
Yamamura M; Hamada Y; Kogata M; Uetsuji S; Kobayashi M; Sakaguchi M; Yamamoto M; Adachi M
Nihon Geka Gakkai Zasshi; 1983 Sep; 84(9):974-7. PubMed ID: 6676668
[TBL] [Abstract][Full Text] [Related]
12. Control of progression of local tumor and pulmonary metastasis of the 3LL Lewis lung carcinoma by different histocompatibility requirements in mice.
Isakov N; Feldman M; Segal S
J Natl Cancer Inst; 1981 May; 66(5):919-26. PubMed ID: 6939934
[TBL] [Abstract][Full Text] [Related]
13. Sensitization of T lymphocytes in vitro by syngeneic macrophages fed with tumor antigens.
Treves AJ; Schechter B; Cohen IR; Feldman M
J Immunol; 1976 Apr; 116(4):1059-64. PubMed ID: 1082902
[TBL] [Abstract][Full Text] [Related]
14. Characterization of two highly metastatic variants of Lewis lung carcinoma with different organ specificities.
Brodt P
Cancer Res; 1986 May; 46(5):2442-8. PubMed ID: 3697987
[TBL] [Abstract][Full Text] [Related]
15. Involvement of doxorubicin-induced Fas expression in the antitumor effect of doxorubicin on Lewis lung carcinoma in vivo.
Yoshimoto Y; Kawada M; Ikeda D; Ishizuka M
Int Immunopharmacol; 2005 Feb; 5(2):281-8. PubMed ID: 15652759
[TBL] [Abstract][Full Text] [Related]
16. Differences in cell surface antigens of tumor metastases and those of the local tumor.
Fogel M; Gorelik E; Segal S; Feldman M
J Natl Cancer Inst; 1979 Mar; 62(3):585-8. PubMed ID: 84091
[TBL] [Abstract][Full Text] [Related]
17. Loss of the H-2.33 private specificity by 3LL tumor cells correlates with the tumor potential to metastasize across the H-2K region genetic barriers.
Isakov N; Feldman M; Segal S
Exp Clin Immunogenet; 1984; 1(3):170-4. PubMed ID: 6401004
[TBL] [Abstract][Full Text] [Related]
18. Influence of teichoic acid from S. aureus on metabolic activity of macrophages and cytotoxic activity of splenocytes of mice bearing Lewis lung carcinoma.
Potebnya GP; Skivka LM; Pozur VV; Rudik MP; Senchilo NV; Fedorchuk OG; Khranovska NM
Exp Oncol; 2008 Sep; 30(3):220-3. PubMed ID: 18806745
[TBL] [Abstract][Full Text] [Related]
19. Rejection of intradermally injected syngeneic tumor cells from mice by specific elimination of tumor-associated macrophages with liposome-encapsulated dichloromethylene diphosphonate, followed by induction of CD11b(+)/CCR3(-)/Gr-1(-) cells cytotoxic against the tumor cells.
Takahashi T; Ibata M; Yu Z; Shikama Y; Endo Y; Miyauchi Y; Nakamura M; Tashiro-Yamaji J; Miura-Takeda S; Shimizu T; Okada M; Ueda K; Kubota T; Yoshida R
Cancer Immunol Immunother; 2009 Dec; 58(12):2011-23. PubMed ID: 19365632
[TBL] [Abstract][Full Text] [Related]
20. Immunotherapy of lethal metastases by lymphocytes sensitized against tumor cells in vitro.
Treves AJ; Cohen IR; Feldman M
J Natl Cancer Inst; 1975 Mar; 54(3):777-80. PubMed ID: 1123855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
